Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/JPET.300.1.142PMID 11752109PMCID PMC6522257
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nephrotoxicity of 4-amino-3-S-glutathionylphenol and its modulation by metabolism or transport inhibitors

  2009cited by this paper
• Phase II study of mitoxantrone for liver metastases from breast cancer

  2004cited by this paper
• Intracellular metabolites of cisplatin in the rat kidney

  2004cited by this paper
• Renal and hepatic toxicity of trichloroethylene and its glutathione-derived metabolites in rats and mice: sex-, species-, and tissue-dependent differences.

  2001cited by this paper
• (cid:2) -Glutamyl Transpeptidase-Deficient Mice Are Resistant to the Nephrotoxic Effects of Cisplatin

  2001cited by this paper
• Metabolism of trichloroethylene.

  2000cited by this paper
• The molecular evolution of pyridoxal-5'-phosphate-dependent enzymes.

  2000cited by this paper
• Gamma-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo.

  1999cited by this paper
• Organ-specific carcinogenicity of haloalkenes mediated by glutathione conjugation

  1999cited by this paper
• Association between expression of glutathione-associated enzymes and response to platinum-based chemotherapy in head and neck cancer.

  1998cited by this paper
• Expression of γ-glutamyl transpeptidase in stage III and IV ovarian surface epithelial carcinomas does not alter response to primary cisplatin-based chemotherapy

  1998cited by this paper
• Glutathione-dependent bioactivation of haloalkenes.

  1998influential reference
• Expression of gamma-glutamyl transpeptidase in stage III and IV ovarian surface epithelial carcinomas does not alter response to primary cisplatin-based chemotherapy.

  1998cited by this paper
• Intranephron distribution of cysteine S -conjugate β-lyase activity and its implication for hexachloro-1,3-butadiene-induced nephrotoxicity in rats

  1997cited by this paper
• The role of glutathione conjugation in the development of kidney tumours in rats exposed to trichloroethylene.

  1997cited by this paper
• Biotransformation and membrane transport in nephrotoxicity.

  1996cited by this paper
• Insights into Mechanisms of Cisplatin Resistance and Potential for Its Clinical Reversal

  1996cited by this paper
• Cisplatin nephrotoxicity: inhibition of gamma-glutamyl transpeptidase blocks the nephrotoxicity of cisplatin without reducing platinum concentrations in the kidney.

  1996cited by this paper
• Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue.

  1996cited by this paper
• Glutamine transaminase K is not a major cysteine S-conjugate beta-lyase of rat kidney mitochondria: evidence that a high-molecular weight enzyme fulfills this role.

  1995cited by this paper
• Cysteine conjugate beta-lyase activity in human renal carcinomas.

  1995cited by this paper
• Enzymology of cysteine S-conjugate beta-lyases.

  1994cited by this paper
• Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide.

  1994cited by this paper
• Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity.

  1994influential reference
• Nephrotoxicity mechanism of cis-platinum (II) diamine dichloride in mice.

  1994cited by this paper
• Enzymology of cysteine S-conjugate beta-lyases.

  1994cited by this paper
• Enzymology of Cysteine S-Conjugote β-Lyases

  1994cited by this paper
• Protection against cisplatin-induced nephrotoxicity in the rat by inducers and an inhibitor of glutathione S-transferase.

  1994cited by this paper
• Bioactivation of nephrotoxins and renal carcinogens by glutathione S-conjugate formation.

  1993cited by this paper
• Nephrotoxicity of the glutathione and cysteine conjugates of 2-bromo-2-chloro-1,1-difluoroethene.

  1992cited by this paper
• Biotransformation of the hexachlorobutadiene metabolites 1-(glutathion-S-yl)-pentachlorobutadiene and 1-(cystein-S-yl)-pentachlorobutadiene in the isolated perfused rat liver.

  1992cited by this paper
• Detection of cysteine conjugate metabolite adduct formation with specific mitochondrial proteins using antibodies raised against halothane metabolite adducts.

  1991cited by this paper
• Role of γ-glutamyltranspeptidase and β-lyase in the nephrotoxicity of hexachloro-1,3-butadiene and methyl mercury in mice

  1990cited by this paper
• The in vivo disposition of 2-bromo-[14C]hydroquinone and the effect of gamma-glutamyl transpeptidase inhibition.

  1990cited by this paper
• Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules.

  1990cited by this paper
• Role of gamma-glutamyltranspeptidase and beta-lyase in the nephrotoxicity of hexachloro-1,3-butadiene and methyl mercury in mice.

  1990cited by this paper
• 2-Bromo-(diglutathion-S-yl)hydroquinone nephrotoxicity: physiological, biochemical, and electrochemical determinants.

  1988cited by this paper
• Mechanism of S-(1,2-dichlorovinyl)glutathione-induced nephrotoxicity.

  1986cited by this paper
• Mitochondrial alterations in cisplatin-induced acute renal failure.

  1986cited by this paper
• A purified cysteine conjugate beta-lyase from rat kidney cytosol. Requirement for an alpha-keto acid or an amino acid oxidase for activity and identity with soluble glutamine transaminase K.

  1986cited by this paper
• Isolation and characterization of a rat liver enzyme with both cysteine conjugate beta-lyase and kynureninase activity.

  1985cited by this paper
• Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin.

  1984cited by this paper
• Metabolism of trichloroethylene.

  1980cited by this paper
• Platinum nephrotoxicity.

  1978cited by this paper
• Platinum nephrotoxicity

  1974cited by this paper

• Physiological Role of Gamma-Glutamyl Transpeptidase: Demise of The Gamma-Glutamyl Cycle.

  2026cites this paper
• 4-Methylpyrazole-mediated inhibition of Cytochrome P450 2E1 protects renal epithelial cells, but not bladder cancer cells, from cisplatin toxicity.

  2025cites this paper
• An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management

  2024cites this paper
• Glutathione S-transferase: A versatile and dynamic enzyme.

  2024cites this paper
• Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches

  2024cites this paper
• Kinetically Inert Platinum (II) Complexes for Improving Anticancer Therapy: Recent Developments and Road Ahead

  2024cites this paper
• The Multifaceted Role of Glutathione S-Transferases in Health and Disease

  2023cites this paper
• SAR of L-ABBA analogs for GGT1 inhibitory activity and L-ABBA's effect on plasma cysteine and GSH species.

  2023cites this paper
• CISPLATIN - AN OVERVIEW OF ITS EFFICIENCY AND TOXICITY

  2023cites this paper
• Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted

  2022cites this paper
• Unexpected Enhancement of Cytotoxicity of Cisplatin in a Rat Kidney Proximal Tubular Cell Line Overexpressing Mitochondrial Glutathione Transport Activity

  2022cites this paper
• An Optimized Two-Herb Chinese Food as Medicine Formula Reduces Cisplatin-Induced Nephrotoxicity in the Treatment of Lung Cancer in Mice

  2022cites this paper
• Ameliorative impacts of polymeric and metallic nanoparticles on cisplatin-induced nephrotoxicity: a 2011–2022 review

  2022cites this paper
• Sensing nitriles with THz spectroscopy of urine vapours from cancers patients subject to chemotherapy

  2022cites this paper
• Cisplatin nephrotoxicity: new insights and therapeutic implications

  2022cites this paper
• Design and evaluation of novel analogs of 2-amino-4-boronobutanoic acid (ABBA) as inhibitors of human gamma-glutamyl transpeptidase

  2022cites this paper
• Cisplatin causes covalent inhibition of protein-tyrosine phosphatase 1B (PTP1B) through reaction with its active site cysteine: Molecular, cellular and in vivo mice studies.

  2022cites this paper
• Review of Research on Gamma-Glutamyl Transferase Pro-Oxidant Effects in Tumor Progression and Cisplatin Resistance

  2022cites this paper
• New combination chemotherapy of cisplatin with an electron-donating compound for treatment of multiple cancers

  2021cites this paper
• Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRASG12C, are associated with renal toxicity in the Sprague Dawley rat.

  2021cites this paper
• Ergothioneine mitigates cisplatin-evoked nephrotoxicity via targeting Nrf2, NF-κB, and apoptotic signaling and inhibiting γ-glutamyl transpeptidase.

  2021cites this paper
• HIF in Nephrotoxicity during Cisplatin Chemotherapy: Regulation, Function and Therapeutic Potential

  2021cites this paper
• Protective Effect of Penetratin Analogue-Tagged SOD1 on Cisplatin-Induced Nephrotoxicity through Inhibiting Oxidative Stress and JNK/p38 MAPK Signaling Pathway

  2021cites this paper
• Cisplatin chemotherapy and renal function.

  2021cites this paper
• Na/H Exchange Regulatory Factor 1 Deficient Mice Show Evidence of Oxidative Stress and Altered Cisplatin Pharmacokinetics

  2021cites this paper
• Amlodipine alleviates cisplatin-induced nephrotoxicity in rats through gamma-glutamyl transpeptidase (GGT) enzyme inhibition, associated with regulation of Nrf2/HO-1, MAPK/NF-κB, and Bax/Bcl-2 signaling

  2020cites this paper
• A Multicompartment Human Kidney Proximal Tubule-on-a-Chip Replicates Cell Polarization–Dependent Cisplatin Toxicity

  2020cites this paper
• Cystathionine-β-synthase: Molecular Regulation and Pharmacological Inhibition

  2020cites this paper
• 1H NMR toxicometabolomics following cisplatin-induced nephrotoxicity in male rats.

  2019cites this paper
• Molecular mechanisms of Cisplatin- induced placental toxicity and teratogenicity in rats and the ameliorating role of N-acetyl-cysteine.

  2019cites this paper
• Loss of the Na+/H+ Exchange Regulatory Factor 1 Increases Susceptibility to Cisplatin-Induced Acute Kidney Injury.

  2019cites this paper
• Differences in binding kinetics, bond strength and adduct formation between Pt‐based drugs and S‐ or N‐donor groups: A comparative study using mass spectrometry techniques

  2019cites this paper
• Cisplatin nephrotoxicity: a review of the literature

  2018cites this paper
• Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges

  2018cites this paper
• Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy

  2018cites this paper
• Mangiferin attenuates cisplatin-induced acute kidney injury in rats mediating modulation of MAPK pathway

  2018cites this paper
• Toxicological safety evaluation of 3,3′‐diselenodipropionic acid (DSePA), a pharmacologically important derivative of selenocystine

  2018influential citation
• Pharmacological Evaluation of Methanolic Extract of Aerial Parts of Helicanthes Elastica (Decr) Danser for its Antiurolithiatic and Nephroprotective Activity

  2017cites this paper
• Possible involvement of the lipoxygenase and leukotriene signaling pathways in cisplatin-mediated renal toxicity

  2017cites this paper
• Renal Medulla is More Sensitive to Cisplatin than Cortex Revealed by Untargeted Mass Spectrometry-Based Metabolomics in Rats

  2017cites this paper
• Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity

  2017cites this paper
• Protective Effects of Dendrobium nobile against Cisplatin Nephrotoxicity Both In-vitro and In-vivo

  2017cites this paper
• A Novel Combination Therapy of Cisplatin with a Molecular Promoter for Cancer Treatment

  2017cites this paper
• Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury

  2017cites this paper
• Suramin protects from cisplatin-induced acute kidney injury

  2017cites this paper
• Sexual differentiation and reproductive development of female rat offspring after paternal exposure to the anti-tumor pharmaceutical cisplatin.

  2016cites this paper
• Suramin Protects From Cisplatin‐Induced Acute Kidney Injury

  2016cites this paper
• Non-cytochrome P450-mediated bioactivation and its toxicological relevance

  2016cites this paper
• Chrysanthemum indicum Attenuates Cisplatin-induced Nephrotoxicity both in vivo and in vitro

  2015influential citation
• Trichosanthes kirilowii ameliorates cisplatin-induced nephrotoxicity in both in vitro and in vivo

  2015cites this paper
• Cysteine Specific Targeting of the Functionally Distinct Peroxiredoxin and Glutaredoxin Proteins by the Investigational Disulfide BNP7787

  2015cites this paper
• The possible protective effect of Nigella sativa seeds on cisplatin-induced acute nephrotoxicity in the rat renal cortex (Histological and Electron Microscopic study)

  2015cites this paper
• Interactions of cisplatin with non-DNA targets and their influence on anticancer activity and drug toxicity: the complex world of the platinum complex.

  2015cites this paper
• In Vitro and In Vivo Studies of Non-Platinum-Based Halogenated Compounds as Potent Antitumor Agents for Natural Targeted Chemotherapy of Cancers

  2015cites this paper
• Pharmacodynamics and pharmacokinetics of oral topotecan in patients with advanced solid tumours and impaired renal function.

  2015cites this paper
• Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometric (LC/ESI-MS/MS) Study for the Identification and Characterization of In Vivo Metabolites of Cisplatin in Rat Kidney Cancer Tissues: Online Hydrogen/Deuterium (H/D) Exchange Study

  2015cites this paper
• Renal Toxicology/Nephrotoxicity of Cisplatin and Other Chemotherapeutic Agents

  2014cites this paper
• Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma

  2014cites this paper
• Vitamin B6 dose-dependently ameliorates renal hemodynamic toxicity of cisplatin in rat model of nephrotoxicity: the histopathologic and biochemical findings

  2014cites this paper
• Transgenic expression of the human MRP2 transporter reduces cisplatin accumulation and nephrotoxicity in Mrp2-null mice.

  2014cites this paper
• Gamma-glutamyl transpeptidase: redox regulation and drug resistance.

  2014cites this paper
• Effect of Misoprostol on Ultrastructural Changes of Renal Tissues in Cisplatin-Treated Adult Rats

  2013cites this paper
• Preparation, characterization and anticancer therapeutic efficacy of cisplatin-loaded niosomes

  2013cites this paper
• Effect of foetal and adult stem cells in acute and chronic kidney diseases

  2013cites this paper
• Magnesium Salts in a Cancer Patient: Pathobiology and Protective Functions

  2013cites this paper
• Studies on the protective effect of dietary fish oil on cisplatin induced nephrotoxicity in rats.

  2012cites this paper
• Nickel, Ruthenium, Rhodium, Palladium, Osmium, and Platinum

  2012cites this paper
• Tannic acid mitigates cisplatin-induced nephrotoxicity in mice

  2012cites this paper
• Platycodin D, a triterpenoid sapoinin from Platycodon grandiflorum, ameliorates cisplatin-induced nephrotoxicity in mice.

  2012cites this paper
• The Journal of Toxicological Sciences

  2012cites this paper
• Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update

  2012cites this paper
• Evaluation of renal protective effects of the green-tea (EGCG) and red grape resveratrol: role of oxidative stress and inflammatory cytokines

  2011cites this paper
• Possible role of cysteine-S-conjugate β-lyase in species differences in cisplatin nephrotoxicity.

  2011cites this paper
• Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats

  2011cites this paper
• Food and Chemical Toxicology, 2011, 'Possible role of cysteine-S-conjugate β-lyase in species differences in cisplatin nephrotoxicity', R. Katayama, S. Nagata, H. Iida, N. Yamagishi, T. Yamashita, K. Furuhama.

  2011cites this paper
• Nephroprotective Effect of <i>Nigella Sativa</i> and <i>Matricaria Chamomilla</i> in Cisplatin Induced Renal Injury—Supportive Treatments in Cisplatin Nephrotoxicity

  2011cites this paper
• Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NFκB, TNF-α and caspase-3 expression in wistar rats.

  2011cites this paper
• Studies on the protective effect of fish oil against cisplatin induced hepatotoxicity

  2011cites this paper
• Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of human aminopeptidase N

  2011cites this paper
• Accumulation of BNP7787 in human renal proximal tubule cells.

  2011cites this paper
• THE EFFECTS OF L-ARGININE ON URINARY NITRIC OXIDE METABOLITES AND RENAL LIPID PEROXIDATION IN CISPLATIN TREATED RATS

  2010cites this paper
• Protective effects of a glutathione disulfide mimetic (NOV-002) against cisplatin induced kidney toxicity.

  2010cites this paper
• Attenuation of cisplatin-induced nephrotoxicity in rats using zerumbone

  2010cites this paper
• The Role of Drug Metabolism in Toxicity

  2010cites this paper
• Role of Bioactivation Reactions in Chemically Induced Nephrotoxicity

  2010cites this paper
• Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients

  2010cites this paper
• Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of gamma-glutamyl transpeptidase

  2010influential citation
• Mechanisms of Cisplatin Nephrotoxicity

  2010cites this paper
• Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical research perspective

  2010cites this paper
• Metabolism of cisplatin to a Nephrotoxin [Toxicology, 257(3), 174–175, doi 10.1016/j.tox.2008.12.014]

  2009cites this paper
• Multiplexed assay panel of cytotoxicity in HK-2 cells for detection of renal proximal tubule injury potential of compounds.

  2009cites this paper
• The immediate early genes, c-fos, c-jun and AP-1, are early markers of platinum analogue toxicity in human proximal tubular cell primary cultures.

  2009cites this paper
• Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting.

  2009cites this paper
• Role of glutathione S-transferase Pi in cisplatin-induced nephrotoxicity.

  2009cites this paper
• Metabolism of cisplatin to a nephrotoxin.

  2009cites this paper
• Influence of dosing schedules on toxicity and antitumour effects of combined cisplatin and docetaxel treatment in mice

  2009cites this paper
• Cisplatin: a review of toxicities and therapeutic applications.

  2008cites this paper
• Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.

  2008cites this paper
• Selection of agents for prevention of cisplatin-induced hepatotoxicity.

  2008cites this paper
• Pharmacological aspects of nephrotoxicity

  2008cites this paper